KLF7通过抑制缺氧诱导因子1α转录影响肉鸡脂肪组织发育

Krüppel样转录因子7(Krüppel-like factor 7, KLF7)是脂肪形成的负调控因子,而缺氧诱导因子1(hypoxia-inducible factor 1, HIF1)促进缺氧诱导的哺乳动物脂肪组织发育。本实验室前期利用ChIP-seq技术,发现在鸡的缺氧诱导因子1α(hypoxia-inducible factor 1 alpha, HIF1α)基因上游存在1个KLF7的结合峰,提示KLF7可能调控HIF1α基因转录。为此,本研究首先利用ChIP-PCR技术验证ChIP-seq结果,发现KLF7能够与HIF1α基因5′侧翼区结合。双荧光素酶报告基因与qRT-PCR结果显示,过表达KLF7能够显著下调HIF1α(-4 432/-4 182)的荧光素酶报告基因活性（P<0.01）,抑制HIF1α基因表达。与野生型质粒相比,将生物信息学预测的KLF7结合基序“TGCGCAGCAA”(-4 300/-4 290)缺失突变后, HIF1α(-4 432/-4 182)报告基因活性显著增强（P<0.01）。此外,选取第19代1～7周龄东北农业大学高、低脂双向选择品系肉鸡(Northeast Agricultural University broiler lines divergently selected for abdominal fat content, NEAUHLF)作为实验材料,利用qRT-PCR检测HIF1α基因在肉鸡腹部脂肪组织中的表达规律。结果显示,HIF1α在1～7周龄高脂系肉鸡中的相对表达量均高于低脂系,提示HIF1α对鸡脂肪组织发育具有促进作用。在永生化鸡前体脂肪细胞系(immortalized chicken preadipocyte cell line, ICP1)诱导分化过程中,HIF1α相对表达量逐渐升高。综上所述,HIF1α是转录因子KLF7的一个靶基因,KLF7可能通过抑制HIF1α基因转录参与鸡脂肪组织发育过程。     

多种翻译后修饰对低氧诱导因子-1α稳定性调控的机制

低氧诱导因子-1（hypoxia-inducible factor-1, HIF-1）是组织细胞对缺氧感应和调控的一类关键转录因子,在机体中广泛表达.作为细胞低氧应答反应中的重要调节因子,HIF-1能够调节100多种涉及低氧应激下细胞适应和存活的靶基因. HIF-1是由氧依赖的α亚基和细胞内稳定表达的β亚基构成的异源二聚体.其中α亚基对氧浓度变化敏感,是HIF-1的功能性亚基,它的表达活性决定了HIF-1的生物学活性.近期研究发现,HIF-1α的一系列翻译后修饰可改变其稳定性,进而调控其转录激活活性,从而参与肿瘤、低氧性肺动脉高压以及心血管疾病等的发生与发展.本文主要就HIF-1α的一列系翻译后修饰,如羟基化、泛素化、磷酸化、乙酰化、SUMO化修饰作一综述.     

缺氧诱导因子1

缺氧诱导因子1是缺氧诱导细胞所产生的一种蛋白质,由一个120 ku的α亚基和一个91～94 ku的β亚基组成的异源二聚体.在缺氧条件下,促进红细胞生成素和糖酵解酶等基因的转录和表达,维持机体氧稳态.     

缺氧诱导因子1研究进展

缺氧诱导因子１（ｈｙｐｏｘｉａ－ｉｎｄｕｃｉｂｌｅ ｆａｃｔｏｒ－１,ＨＩＦ－１）是由两个蛋白质亚基组成的二聚体转录因子,对缺氧具有特异感受性,它的表达受细胞内氧分压的严密调节。ＨＩＦ－１参与体内许多缺氧反应性基因的转录调节,是机体缺氧应答反应中的关键作用因子。     

缺氧诱导因子1与缺氧信号转导机制

缺氧诱导因子1(HIF-1)不仅作为维持氧自稳平衡的核心调控因子,调控一系列缺氧相关基因的表达,而且在感受缺氧,传递缺氧信号的过程中发挥重要作用。氧依赖的羟化酶的发现,证明胞内氧浓度直接调控HIF-1α亚基的表达,为揭示缺氧信号调控HIF-1表达的分子机制提供了有力的证据。     

缺氧诱导因子-1α表达在胃癌中的研究进展

胃癌是人类最常见的恶性肿瘤之一,严重威胁着人类的健康。大量研究表明,缺氧能促进恶性肿瘤的发展,增强其侵袭性,而缺氧诱导因子-1α(HIF-1α)是这一过程的主要调节因子,是缺氧条件下广泛存在于哺乳动物及人体内的一种转录因子,通过增加多种转录因子和靶基因产物的表达,使肿瘤在缺氧的环境下生长、增殖、侵袭及转移。本文就HIF-1α在胃癌领域的研究进展做一综述。     

缺氧诱导因子-1α与血管内皮生长因子及其受体2在大鼠3期压力性损伤皮肤组织中的表达及意义*

目的:分析缺氧诱导因子-1α(HIF-1α)、血管内皮生长因子(VEGF)和血管内皮生长因子受体2(KDR)在不同受压时间点大鼠压力性损伤局部皮肤组织中的表达及相互关系,探讨3期压力性损伤慢性难愈的可能机制。方法:将40只SD雄性大鼠随机分为正常对照组、受压3 d、5 d、7 d、 9 d组( n=8 ),使用磁铁压迫法建立3期压力性损伤动物模型。HE染色观察皮肤组织形态;免疫组化法检测VEGF表达,Western blot 检测皮肤组织HIF-1α、VEGF、KDR蛋白表达;对数据行单因素方差分析、LSD检验。结果:①HE结果显示,与正常对照组相比,受压组大鼠表皮逐渐增厚,血管数量不断减少,胶原排列紊乱,炎症细胞浸润增加。②免疫组化结果显示:受压3 d组大鼠皮肤组织中VEGF蛋白表达量较正常对照组明显增高(P＜0.01);受压5 d、7 d和 9 d组大鼠皮肤组织中VEGF蛋白表达量均明显低于正常对照组(P＜0.05)。WB结果和免疫组化结果一致。③WB结果显示:受压3 d、5 d和7 d组大鼠皮肤组织中HIF-1α表达量均明显高于正常对照组(P＜0.01 或 P＜0.05);4组受压组大鼠皮肤组织KDR蛋白表达量均低于正常对照组(P＜0.05或P＜0.01)。结论:HIF-1α介导的VEGF和KDR蛋白表达减少引起组织血管生成减少可能是3期压力性损伤慢性难愈的重要原因之一。     

缺氧诱导因子-1α与胰腺癌发生发层的关系

缺氧是实体瘤生长中存在的普遍现象,它和肿瘤的发展、侵润、转移密切相关。研究发现在胰腺癌组织中也存在缺氧现象。缺氧诱导因子(hypoxia-inducible factor-1,HIF-1)是缺氧条件下广泛存在于哺乳动物及人体中的一种转录因子,它是由α亚基和β亚基组成的异源二聚体。HIF-1α是HIF-1的活性部分,其表达与胰腺癌的血管生成、凋亡抑制、多药耐药、生长转移具有密切关系。同时,缺氧状态下,间质细胞与胰腺癌细胞之间的相互作用促进了癌细胞的侵袭力。现就HIF-1α在胰腺癌组织中的表达及作用做一综述。     

缺氧诱导因子-1结构及功能的研究进展

缺氧诱导因子(hypoxia inducible factor-1,HIF-1)是一种介导机体对缺氧环境产生应答的转录因子。在炎症及实体肿瘤周围的组织大多存在缺氧现象。在缺氧条件下,HIF-1α和HIF-1β两个亚基结合,形成HIF-1并迅速活化,参与机体缺氧环境的适应,并在胚胎发育、多种肿瘤及心肺疾病等发生发展中起到重要作用。因此,更好地认识HIF-1的功能及意义,对进一步地认识与其相关生命过程和疾病本质以及研发新的治疗手段具有重要意义。     

离心力和剪应力应答蛋白1是肿瘤坏死因子受体1的新调控因子

离心力和剪应力应答基因1(responsive to centrifugal force and shear stress gene 1,RECS1)被剔除的小鼠易患囊性内侧坏死和动脉扩张症,伴随着血管组织基质金属蛋白酶9表达水平的增强.本室前期研究发现,稳定表达RECS1的小鼠成纤维细胞对肿瘤坏死因子受体2激动性抗体的敏感性被明显弱化,显示RECS1参与肿瘤坏死因子信号的调控.本文研究了RECS1对肿瘤坏死因子受体1（tumor necrosis factor receptor-1, TNFR1）的调控作用.结果显示,RECS1结合TNFR1,并抑制过量表达TNFR1诱导的核转录因子-κB (NF-κB)活化.缺失突变研究发现,RECS1分子上有NPLY和SPEDY两个模体是其抑制TNFR1信号所必需的.免疫共沉淀实验发现,NPLY是RECS1与TNFR1结合所必需的.而SPEDY的缺失不影响RECS1与TNFR1的结合.另外,免疫共染色实验显示,RECS1与TNFR1共定位于细胞内核体.这些实验结果进一步揭示了RECS1负调控肿瘤坏死因子-α(tumor necrosis factor-α, TNF-α)信号进而参与调控血管发育与重塑的生物功能及可能机理.     

Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2)

Inhibition of HIF-1alpha activity provides an important strategy for the treatment of cancer. Recently, 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) has been identified as an anti-HIF-1alpha drug in cancer therapy with unclear molecular mechanism. In the present study, we aimed to investigate the effect and mechanism of YC-1 on HIF-1alpha in a hepatocellular carcinoma cell line under hypoxic condition, which was generated by incubating cells with 0.1% O(2). The phenotypic and molecular changes of cells were determined by cell proliferation assay, apoptosis assay, luciferase promoter assay, and Western blot analysis. YC-1 arrested tumor cell growth in a dose-dependent manner, whereas it did not induce cell apoptosis. Hypoxia-induced upregulation of HIF-1alpha was suppressed by YC-1 administration. YC-1 inhibited HIF-1alpha protein synthesis under normoxia and affected protein stability under hypoxia. YC-1 suppressed the expression of total and phosphorylated forms of murine double minute 2 (Mdm2), whereas this inhibitory effect was blocked by overexpression of Mdm2. In conclusion, YC-1 suppressed both protein synthesis and stability of HIF-1alpha in HCC cells, and its inhibitory effects on HIF-1alpha were dependent on Mdm2.     

Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor-1

Hepatocyte growth factor (HGF) plays an important role in tumor growth and progression also by regulating invasive/metastatic phenotype and angiogenesis. Here we report that a molecular mechanism possibly contributing to these functions of HGF may be hypoxia inducible factor-1 (HIF-1)-dependent expression of genes of the plasminogen activation system. The following findings support this conclusion: (1) HGF enhanced the activity of a luciferase reporter construct under the control of multiple HIF-1 responsive elements (HRE) in HepG2 cells, and the cotransfection of the dominant negative for the beta-subunit (ARNT) prevented this increase; (2) HGF activated uPA and PAI-1 promoters through HIF-1 activity regulated by PI3K/JNK1 transducers, as demonstrated by cotransfection with the reporter gene promoters and the dominant negative for ARNT, p85 subunit of PI3K or JNK1; (3) hypoxia was additive to HGF in increasing reporter vector activities, but probably through different transduction pathways; (4) JNK1 wild-type expression vector increased HIF-1alpha protein expression probably in a phosphorylated state and, thus, functional for transactivating activity; and (5) c-Jun did not seem to be involved in the activation of the luciferase construct containing multiple HREs because it was not prevented by expression of TAM-67, which is the dominant negative mutant form for c-Jun.     

The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses

The non-structural protein (NS1) of influenza A viruses (IAV) performs multiple functions during viral infection. NS1 contains two nuclear localization signals (NLS): NLS1 and NLS2. The NS1 protein is located predominantly in the nucleus during the early stages of infection and subsequently exported to the cytoplasm. A nonsense mutation that results in a large deletion in the carboxy-terminal region of the NS1 protein that contains the NLS2 domain was found in some IAV subtypes, including highly pathogenic avian influenza (HPAI) H7N9 and H5N1 viruses. We introduced different mutations into the NLS domains of NS1 proteins in various strains of IAV, and demonstrated that mutation of the NLS2 region in the NS1 protein of HPAI H5N1 viruses severely affects its nuclear localization pattern. H5N1 viruses expressing NS1 protein that is unable to localize to the nucleus are less potent in antagonizing cellular antiviral responses than viruses expressing wild-type NS1. However, no significant difference was observed with respect to viral replication and pathogenesis. In contrast, the replication and antiviral defenses of H1N1 viruses are greatly attenuated when nuclear localization of the NS1 protein is blocked. Our data reveals a novel functional plasticity for NS1 proteins among different IAV subtypes.     

Plasma proteomic analysis of patients infected with H1N1 influenza virus

This study profiled the plasma proteins of patients infected by the 2011 H1N1 influenza virus. Differential protein expression was identified in plasma obtained from noninfected control subjects (n = 15) and H1N1‐infected subjects (n = 15). Plasma proteins were separated by a 2DE large gel system and identified by nano‐ultra performance LC‐MS. Western blot assays were performed to validate proteins. Eight plasma proteins were upregulated and six proteins were downregulated among 3316 plasma proteins in the H1N1‐infected group as compared with the control group. Of 14 up‐ and downregulated proteins, nine plasma proteins were validated by Western blot analysis. Putative protein FAM 157A, leucine‐rich alpha 2 glycoprotein, serum amyloid A protein, and dual oxidase 1 showed significant differential expression. The identified plasma proteins could be potential candidates for biomarkers of H1N1 influenza viral infection. Further studies are needed to develop these proteins as diagnostic biomarkers.     

The signaling pathway of hypoxia inducible factor and its role in renal diseases

Abstract

It is well-documented that hypoxia inducible factor (HIF) is a key mediator of tissue and cellular adaptation to hypoxia. HIF-target genes are also involved in cellular apoptosis and profibrotic mechanisms. The role of HIF in diseases is not consistent. It is a risk factor for tumor progression, whereas it plays a protective role against ischemic hypofusion. For renal diseases, it is not always a risk or protective factor. Many factors are involved in the pathogenesis of renal diseases. It is reported that HIF not only increases hypoxia tolerance, but also regulates a lot of signaling pathways. In the past decades, a number of studies were also conducted to explore the association between HIF and the risk of renal diseases. However, the role of HIF in the development of renal diseases was not entirely clear. In this study, the signal transduction pathways of HIF and its role in the pathogenesis of renal diseases were reviewed.